231 related articles for article (PubMed ID: 4037991)
21. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
Schweitzer I; Tuckwell VM; Maguire KP; Tiller JW; Harrison LC; Davies BM
Psychoneuroendocrinology; 1991; 16(5):375-82. PubMed ID: 1805291
[TBL] [Abstract][Full Text] [Related]
22. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
[TBL] [Abstract][Full Text] [Related]
23. Multiple depressive episodes and plasma postdexamethasone cortisol levels.
Meador-Woodruff JH; Gurguis G; Grunhaus L; Haskett RF; Greden JF
Biol Psychiatry; 1987 May; 22(5):583-92. PubMed ID: 3580433
[TBL] [Abstract][Full Text] [Related]
24. Cortisol escape from suppression by dexamethasone during depression is strongly predicted by basal cortisol hypersecretion and increasing age combined.
Maes M; Minner B; Suy E; D'Hondt P; Jacobs MP; Raus J
Psychoneuroendocrinology; 1991; 16(4):295-310. PubMed ID: 1745698
[TBL] [Abstract][Full Text] [Related]
25. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
Amsterdam JD; Maislin G; Winokur A; Kling M; Gold P
Arch Gen Psychiatry; 1987 Sep; 44(9):775-81. PubMed ID: 2820340
[TBL] [Abstract][Full Text] [Related]
26. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.
Yehuda R; Southwick SM; Krystal JH; Bremner D; Charney DS; Mason JW
Am J Psychiatry; 1993 Jan; 150(1):83-6. PubMed ID: 8417586
[TBL] [Abstract][Full Text] [Related]
27. The dexamethasone suppression test in prepubertal depressed children.
Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
Thompson LM; Rubin RT; McCracken JT
Psychoneuroendocrinology; 1992 Oct; 17(5):507-15. PubMed ID: 1484917
[TBL] [Abstract][Full Text] [Related]
29. Circadian analysis of plasma cortisol levels before and after dexamethasone administration in depressed patients.
Sherman B; Pfohl B; Winokur G
Arch Gen Psychiatry; 1984 Mar; 41(3):271-5. PubMed ID: 6703845
[TBL] [Abstract][Full Text] [Related]
30. Abnormal pituitary function during melancholia: reduced alpha-melanocyte-stimulating hormone secretion and increased intact ACTH non-suppression.
Maes M; DeJonckheere C; Vandervorst C; Schotte C; Cosyns P; Raus J; Suy E
J Affect Disord; 1991 Jul; 22(3):149-57. PubMed ID: 1655852
[TBL] [Abstract][Full Text] [Related]
31. Impact of sleep deprivation and subsequent recovery sleep on cortisol in unmedicated depressed patients.
Voderholzer U; Hohagen F; Klein T; Jungnickel J; Kirschbaum C; Berger M; Riemann D
Am J Psychiatry; 2004 Aug; 161(8):1404-10. PubMed ID: 15285966
[TBL] [Abstract][Full Text] [Related]
32. Salivary cortisol: a practical method for evaluation of adrenal function.
Kahn JP; Rubinow DR; Davis CL; Kling M; Post RM
Biol Psychiatry; 1988 Feb; 23(4):335-49. PubMed ID: 3257706
[TBL] [Abstract][Full Text] [Related]
33. [The dexamethasone suppression test in depression. Critical review].
Bailly D; Goudemand M; Parquet PJ
Encephale; 1984; 10(4):155-69. PubMed ID: 6389093
[TBL] [Abstract][Full Text] [Related]
34. Cortisol levels in plasma after dexamethasone administration and the nosology of depression.
Sanchez Blanque A; Fernandez Canti G; Gimenez Morales JC; Juste Rullo G
Acta Psychiatr Belg; 1985; 85(3):406-15. PubMed ID: 4050499
[TBL] [Abstract][Full Text] [Related]
35. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
[TBL] [Abstract][Full Text] [Related]
36. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression.
Claustrat B; Chazot G; Brun J; Jordan D; Sassolas G
Biol Psychiatry; 1984 Aug; 19(8):1215-28. PubMed ID: 6498244
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns.
Rubin RT; Poland RE; Lesser IM; Martin DJ; Blodgett AL; Winston RA
Psychol Med; 1987 Aug; 17(3):609-19. PubMed ID: 3628622
[TBL] [Abstract][Full Text] [Related]
38. Intermediate glucocorticoid feedback of corticotropin secretion in patients with major depression.
Kellner M; Holsboer F; Heuser I
Psychiatry Res; 1995 Nov; 59(1-2):157-60. PubMed ID: 8771231
[TBL] [Abstract][Full Text] [Related]
39. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
Kathol RG; Jaeckle RS; Lopez JF; Meller WH
Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
[TBL] [Abstract][Full Text] [Related]
40. Plasma endogenous opioids and dexamethasone suppression test in depression.
Kärkkäinen J; Laatikainen T; Naukkarinen H; Salminen K; Spoov J; Stenman UH; Rimon R
Psychiatry Res; 1987 Jun; 21(2):151-9. PubMed ID: 2956623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]